During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I take any new medications, I research them, first through a generative AI tool ...

We look forward to that as it’ll be a big help to anyone trying to hack diabetes care. Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support improvements in overall health and wellness.

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

AbbottAs a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He's also taken on more than a few challe ...

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

Abbott (NYSE:ABT) today unveiled a new initiative addressing the biases and stigmas associated with diabetes management.

Bengaluru: Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to ...